Access Course

The latest advances in immunotherapy for CRC, HCC, and gastroesophageal cancers are explored in these 3 columns.

This activity is intended for oncologists, gastroenterologists, and other healthcare professionals who treat patients with gastrointestinal (GI) cancers.

The goal of this activity is to increase understanding of the advances and challenges of using checkpoint inhibitors in the treatment of patients with GI cancers.

Learning Objectives:

• Have increased knowledge regarding the clinical trial data on the use of immune checkpoint inhibitors (ICIs) alone or in combination in patients with advanced or metastatic GI cancers
• ICI treatment strategies for patients with GI cancers in the community oncology setting

Approximate Time to Complete: 1 hour

Credit Available: November 27, 2019 - November 27, 2020

Developed through a partnership between SITC and Medscape.

Additional Resources for Clinicans from SITC:

View Available Guidelines Here.